High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV
Authors:
- Nadira VadaqNVNadira Vadaq
- Yue ZhangYZYue Zhang
- Wilhelm A.J.W. VosWVWilhelm A.J.W. Vos
- Albert L. GroenendijkAGAlbert L. Groenendijk
- Martinus J.T. BlaauwMBMartinus J.T. Blaauw
- Louise E. van EekerenLELouise E. van Eekeren
- Muhammad Hussein GasemMGMuhammad Hussein Gasem
- Leo A.B. JoostenLJLeo A.B. Joosten
- Mihai G. NeteaMNMihai G. Netea
Open Access
- 8 June 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (11)
Abstract
BACKGROUND: People living with HIV (PLHIV) receiving antiretroviral therapy (ART) exhibit persistent immune dysregulation and microbial dysbiosis, leading to development of cardiovascular diseases (CVDs). We initially compared plasma proteomic profiles between 205 PLHIV and 120 healthy control participants (HCs) and validated the results in an independent cohort of 639 PLHIV and 99 HCs. Differentially expressed proteins (DEPs) were then associated to microbiome data. Finally, we assessed which proteins were linked with CVD development in PLHIV. METHODS: Proximity extension assay technology was used to measure 1,472 plasma proteins. Markers of systemic inflammation (C-reactive protein, D-dimer, IL-6, soluble CD14, and soluble CD163) and microbial translocation (IFABP) were measured by ELISA, and gut bacterial species were identified using shotgun metagenomic sequencing. Baseline CVD data were available for all PLHIV, and 205 PLHIV were recorded for development of CVD during a 5-year follow-up. RESULTS: PLHIV receiving ART had systemic dysregulation of protein concentrations, compared with HCs. Most of the DEPs originated from the intestine and lymphoid tissues and were enriched in immune- and lipid metabolism–related pathways. DEPs originating from the intestine were associated with specific gut bacterial species. Finally, we identified upregulated proteins in PLHIV (GDF15, PLAUR, RELT, NEFL, COL6A3, and EDA2R), unlike most markers of systemic inflammation, associated with the presence and risk of developing CVD during 5-year follow-up. CONCLUSION: Our findings suggest a systemic dysregulation of protein concentrations in PLHIV; some proteins were associated with CVD development. Most DEPs originated from the gut and were related to specific gut bacterial species. TRIAL REGISTRATION: ClinicalTrials.gov NCT03994835. FUNDING: AIDS-fonds (P-29001), ViiV healthcare grant (A18-1052), Spinoza Prize (NWO SPI94-212), European Research Council (ERC) Advanced grant (grant 833247), and Indonesia Endowment Fund for Education.Keywords
This publication has 92 references indexed in Scilit:
- Soluble CD163 Made by Monocyte/Macrophages Is a Novel Marker of HIV Activity in Early and Chronic Infection Prior to and After Anti-retroviral TherapyThe Journal of Infectious Diseases, 2011
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV InfectionThe Journal of Infectious Diseases, 2011
- Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activationAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Causes of Death in HIV‐1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort StudiesClinical Infectious Diseases, 2010
- Th17 and regulatory T cells: implications for AIDS pathogenesisCurrent Opinion in HIV and AIDS, 2010
- Adipose Tissue Collagen VI in ObesityThe Journal of Clinical Endocrinology & Metabolism, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Fatty acid-binding proteins: role in metabolic diseases and potential as drug targetsNature Reviews Drug Discovery, 2008
- Understanding the benign nature of SIV infection in natural hostsJournal of Clinical Investigation, 2007
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006